Cushing's Syndrome
Conditions
Keywords
Cushing's Syndrome, Mifepristone, Adrenal, Retrospective, Chart Review
Brief summary
Chart review study to collect patient data from medical charts of patients who have been treated with Korlym® for the treatment of ACTH independent adrenal Cushing's Syndrome.
Detailed description
A retrospective, multi-center, chart review study to collect patient data from medical charts of patients who have been treated with Korlym® for the treatment of ACTH independent adrenal Cushing's Syndrome. Treatment with Korlym® will be a minimum 3 months in duration with follow-up of a minimum 3 months. Only sites that have been identified to have patients appropriate for this protocol will be invited to participate.
Interventions
OTHERNo intervention
No treatment (intervention) was administered.
Sponsors
Corcept Therapeutics
Study design
Observational model
CASE_ONLY
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
No
Inclusion criteria
* Diagnosed with ACTH independent endogenous Cushing's Syndrome * Available adrenal imaging prior to being treated with Korlym® * Treated with Korlym® and followed for at least 3 months (follow-up data should be available)
Exclusion criteria
* Diagnosed with adrenocortical carcinoma * Participant in any clinical trial(s) during the observational period
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Drug Utilization Patterns as assessed by chart review | up to 4 years | The retrospective review would analyze the drug utilization patterns of patients treated with Korlym |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Clinical Outcomes as assessed by chart review | up to 4 years | The retrospective review would analyze outcomes measures (vitals, clinical assessments, etc) in patients treated with Korlym |
Outcome results
None listed